These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. C-terminal repeats of Clostridium difficile toxin A induce production of chemokine and adhesion molecules in endothelial cells and promote migration of leukocytes. Yeh CY, Lin CN, Chang CF, Lin CH, Lien HT, Chen JY, Chia JS. Infect Immun; 2008 Mar; 76(3):1170-8. PubMed ID: 18160482 [Abstract] [Full Text] [Related]
23. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods]. Altindiş M, Usluer S, Ciftçi H, Tunç N, Cetinkaya Z, Aktepe OC. Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550 [Abstract] [Full Text] [Related]
29. Construction of a non toxic chimeric protein (L1-L2-B) of Haemolysin BL from Bacillus cereus and its application in HBL toxin detection. Kumar TD, Murali HS, Batra HV. J Microbiol Methods; 2008 Dec 01; 75(3):472-7. PubMed ID: 18718851 [Abstract] [Full Text] [Related]
30. Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Jank T, Aktories K. Trends Microbiol; 2008 May 01; 16(5):222-9. PubMed ID: 18394902 [Abstract] [Full Text] [Related]
32. Functional and structural characterization of soluble recombinant epsilon toxin of Clostridium perfringens D, causative agent of enterotoxaemia. Mathur DD, Deshmukh S, Kaushik H, Garg LC. Appl Microbiol Biotechnol; 2010 Oct 01; 88(4):877-84. PubMed ID: 20676627 [Abstract] [Full Text] [Related]
33. [Comparison of three enzyme immunoassays for detection of Clostridium difficile toxins A and B]. Ould-Hocine ZF, Djibo N, Deforges L, Legrand P, Cattoir V. Pathol Biol (Paris); 2008 Oct 01; 56(7-8):424-8. PubMed ID: 18824307 [Abstract] [Full Text] [Related]
34. Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity. Egerer M, Giesemann T, Jank T, Satchell KJ, Aktories K. J Biol Chem; 2007 Aug 31; 282(35):25314-21. PubMed ID: 17591770 [Abstract] [Full Text] [Related]
36. Comparison of clinical, microbiologic, and clinicopathologic findings in horses positive and negative for Clostridium difficile infection. Ruby R, Magdesian KG, Kass PH. J Am Vet Med Assoc; 2009 Mar 15; 234(6):777-84. PubMed ID: 19284345 [Abstract] [Full Text] [Related]
37. Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding. Rolfe RD, Song W. J Med Microbiol; 1995 Jan 15; 42(1):10-9. PubMed ID: 7739018 [Abstract] [Full Text] [Related]
38. Identification of the cellular receptor of Clostridium spiroforme toxin. Papatheodorou P, Wilczek C, Nölke T, Guttenberg G, Hornuss D, Schwan C, Aktories K. Infect Immun; 2012 Apr 15; 80(4):1418-23. PubMed ID: 22252869 [Abstract] [Full Text] [Related]
39. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase. Kim H, Kokkotou E, Na X, Rhee SH, Moyer MP, Pothoulakis C, Lamont JT. Gastroenterology; 2005 Dec 15; 129(6):1875-88. PubMed ID: 16344056 [Abstract] [Full Text] [Related]
40. Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C. difficile. Martinez RD, Wilkins TD. J Med Microbiol; 1992 Jan 15; 36(1):30-6. PubMed ID: 1370542 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]